Benzinga
Benzinga
Benzinga
lunes, septiembre 14

Immunome Inc

IMNMNASDAQ
Trade with Public
Trade with Public
$24.67
-0.30-1.2%
al cierre: Sep 10, 5:00 PM EST
$24.46
-0.51-2.04%
Premercado: 5:30 AM EST
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadCompararInforme de acciones

Immunome Financials

Immunome (IMNM) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Immunome Q2 EPS $(0.65) Misses $(0.52) Estimate

Immunome (NASDAQ:IMNM) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0.52) by 25 percent. This is a 30 percent decrease over losses of $(0.50) per share from the same
Benzinga Newsdesk

PRO
Immunome Q1 EPS $(0.48) Beats $(0.57) Estimate

Immunome (NASDAQ:IMNM) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.57) by 15.79 percent. This is a 7.69 percent increase over losses of $(0.52) per share from the same
Benzinga Newsdesk

Immunome: Q4 Earnings Insights

Benzinga Insights

PRO
Immunome Q4 EPS $(0.75) Misses $(0.58) Estimate

Immunome (NASDAQ:IMNM) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate of $(0.58) by 29.09 percent. This is a 41.41 percent increase over losses of $(1.28) per share from the
Benzinga Newsdesk

PRO
Immunome Q3 EPS $(0.65) Misses $(0.58) Estimate

Immunome (NASDAQ:IMNM) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0.58) by 12.26 percent. This is a 16.67 percent increase over losses of $(0.78) per share from the
Benzinga Newsdesk

PRO
Immunome Q2 EPS $(0.50) Beats $(0.55) Estimate, Sales $4.015M May Not Be Comparable To $714.286K Estimate

Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved